Press "Enter" to skip to content

New patent for Eli Lilly drug BAQSIMI

1
Copyright © DrugPatentWatch. Originally published at New patent for Eli Lilly drug BAQSIMI

Annual Drug Patent Expirations for BAQSIMI
Annual Drug Patent Expirations for BAQSIMI

Baqsimi is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

BAQSIMI drug price trends.

This drug has thirty-nine patent family members in thirty countries.

The generic ingredient in BAQSIMI is glucagon. One supplier is listed for this compound. Additional details are available on the glucagon profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Eli Lilly drug BAQSIMI
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!